CPRX earnings date and last-quarter result: last quarter miss, P/E 17.49. Updated 2026-07-23.
Catalyst Pharmaceuticals (CPRX) Research Hub
Catalyst Pharmaceuticals (CPRX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-07-20, shares last closed at 31.49 USD (0.00%), in a uptrend — price above rising 50-DMA, 50-DMA above 200-DMA. Valuation: trailing P/E 17.49, market cap 3.85B. This hub links to the full technical, earnings and options research available for CPRX.
Last updated 2026-07-20 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 31.49 USD (0.00%) |
| 52-week range | 19.05 USD – 32.56 USD |
| Trend regime | Uptrend |
| 14-day RSI | 60 (Bullish) |
| Trailing P/E | 17.49 |
| Market cap | 3.85B |
| Dividend yield | 0.00% |
Available research for CPRX
Covered Call on CPRX: how it works, illustrative setup around the real 31.49 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CPRX: how it works, illustrative setup around the real 31.49 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CPRX: how it works, illustrative setup around the real 31.49 USD price, max profit/loss, breakeven and when to use it. Educational.
CPRX technical analysis: uptrend, last 31.49 USD, RSI 60, 52w range 19.05 USD–32.56 USD, real support/resistance. Updated 2026-07-20.
More on SniperIQ
Frequently asked questions
What sector is CPRX in?
Catalyst Pharmaceuticals (CPRX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CPRX in an uptrend or downtrend?
As of 2026-07-20, CPRX is in a uptrend — price above rising 50-DMA, 50-DMA above 200-DMA. See the full technical research page for support and resistance levels.
What is CPRX's trailing P/E ratio?
CPRX's trailing P/E is 17.49, with a market cap of 3.85B. See the earnings research page for full valuation detail.